Gbp3 is associated with the progression of lupus nephritis by regulating cell proliferation, inflammation and pyroptosis

References

• Kronbichler A, Brezina B, Gauckler P, et al. Refractory lupus nephritis: when, why and how to treat. Autoimmun Rev. 2019;18(5):1–10.
   PubMed Web of Science ®Google Scholar
• Quintero-González DC, Muñoz-Urbano M, Vásquez G. Mitochondria as a key player in systemic lupus erythematosus. Autoimmunity. 2022; 55(8):497–505.
   PubMed Web of Science ®Google Scholar
• Davidson A, Aranow C, Mackay M. Lupus nephritis: challenges and progress. Curr Opin Rheumatol. 2019; 31(6):682–688.
   PubMed Web of Science ®Google Scholar
• Berg SIT, Knapp J, Braunstein M, et al. The small heat shock protein HSPB5 attenuates the severity of lupus nephritis in lupus-prone mice. Autoimmunity. 2022;55(3):192–202. May
   PubMed Web of Science ®Google Scholar
• Hernandez Cruz B, Alonso F, Calvo AJ, et al. Differences in clinical manifestations and increased severity of systemic lupus erythematosus between two groups of Hispanics: European caucasians versus latin American mestizos (data from the RELESSER registry). Lupus. 2020;29(1):27–36. Jan
   PubMed Web of Science ®Google Scholar
• Balow JE. Clinical presentation and monitoring of lupus nephritis. Lupus. 2005;14(1):25–30.
   PubMed Web of Science ®Google Scholar
• Hanly JG, O'Keeffe AG, Su L, et al. The frequency and outcome of lupus nephritis: results from an international inception cohort study. Rheumatology. 2016;55(2):252–262. Feb
   PubMed Web of Science ®Google Scholar
• Gasparotto M, Gatto M, Binda V, et al. Lupus nephritis: clinical presentations and outcomes in the 21st century. Rheumatology. 2020;59(Suppl5):v39–v51. 5
   PubMedGoogle Scholar
• Serrati S, De Summa S, Pilato B, et al. Next-generation sequencing: advances and applications in cancer diagnosis. Onco Targets Ther. 2016;9:7355–7365.
   PubMed Web of Science ®Google Scholar
• Ma L, Jakobiec FA, Dryja TP. A review of next-generation sequencing (NGS): applications to the diagnosis of ocular infectious diseases. Semin Ophthalmol. 2019;34(4):223–231.
   PubMed Web of Science ®Google Scholar
• Qian Y, Gong Y, Fan Z, et al. Molecular alterations and targeted therapy in pancreatic ductal adenocarcinoma. J Hematol Oncol. 2020;13(1):130.
   PubMed Web of Science ®Google Scholar
• Shimada A. Hematological malignancies and molecular targeting therapy. Eur J Pharmacol. 2019; 862:172641.
   PubMed Web of Science ®Google Scholar
• Su YJ, Lin IC, Wang L, et al. Next generation sequencing identifies miRNA-based biomarker panel for lupus nephritis. Oncotarget. 2018;9(46):27911–27919.
   PubMedGoogle Scholar
• Vestal DJ, Jeyaratnam JA. The guanylate-binding proteins: emerging insights into the biochemical properties and functions of this family of large interferon-induced guanosine triphosphatase. J Interferon Cytokine Res. 2011; 31(1):89–97.
   PubMed Web of Science ®Google Scholar
• Praefcke GJK. Regulation of innate immune functions by guanylate-binding proteins. Int J Med Microbiol. 2018; 308(1):237–245.
   PubMed Web of Science ®Google Scholar
• Gu T, Yu D, Fan Y, et al. Molecular identification and antiviral function of the guanylate-binding protein (GBP) genes in the Chinese tree shrew (Tupaia belangeri chinesis). Dev Comp Immunol. 2019;96:27–36.
   PubMed Web of Science ®Google Scholar
• Finethy R, Luoma S, Orench-Rivera N, et al. Inflammasome activation by bacterial outer membrane vesicles requires guanylate binding proteins. mBio. 2017;8(5):e01188–17.
   PubMed Web of Science ®Google Scholar
• Johns CE, Galam L. Guanylate binding protein 1 (GBP1): a key protein in inflammatory pyroptosis. Cell Biochem Biophys. 2022; 80(2):295–299.
   PubMed Web of Science ®Google Scholar
• Corte-Real JV, Baldauf HM, Abrantes J, et al. Evolution of the guanylate binding protein (GBP) genes: emergence of GBP7 genes in primates and further acquisition of a unique GBP3 gene in simians. Mol Immunol. 2021;132:79–81.
   PubMed Web of Science ®Google Scholar
• Xu H, Sun L, Zheng Y, et al. GBP3 promotes glioma cell proliferation via SQSTM1/p62-ERK1/2 axis. Biochem Biophys Res Commun. 2018;495(1):446–453.
   PubMed Web of Science ®Google Scholar
• Xu H, Jin J, Chen Y, et al. GBP3 promotes glioblastoma resistance to temozolomide by enhancing DNA damage repair. Oncogene. 2022;41(31):3876–3885.
   PubMed Web of Science ®Google Scholar
• Oliveira CB, Lima CAD, Vajgel G, et al. The role of NLRP3 inflammasome in lupus nephritis. Int J Mol Sci. 2021;22(22):12476.
   Web of Science ®Google Scholar
• Komada T, Muruve DA. The role of inflammasomes in kidney disease. Nat Rev Nephrol. 2019; 15(8):501–520.
   PubMed Web of Science ®Google Scholar
• Zhang KJ, Wu Q, Jiang SM, et al. Pyroptosis: a new frontier in kidney diseases. Oxid Med Cell Longev. 2021;2021:6686617.
   PubMed Web of Science ®Google Scholar
• Yap DY, Yung S, Chan TM. Lupus nephritis: an update on treatments and pathogenesis. Nephrology. 2018; 23 (Suppl 4):80–83.
   PubMedGoogle Scholar
• Talotta R, Atzeni F, Laska MJ. Retroviruses in the pathogenesis of systemic lupus erythematosus: are they potential therapeutic targets? Autoimmunity. 2020; 53(4):177–191.
   PubMed Web of Science ®Google Scholar
• Feng Y, Yang M, Wu H, et al. The pathological role of B cells in systemic lupus erythematosus: from basic research to clinical. Autoimmunity. 2020;53(2):56–64.
   PubMed Web of Science ®Google Scholar
• Wang T, Fu X, Chen Q, et al. Arachidonic acid metabolism and kidney inflammation. Int J Mol Sci. 2019;20(15):3683.
   Web of Science ®Google Scholar
• Anekthanakul K, Manocheewa S, Chienwichai K, et al. Predicting lupus membranous nephritis using reduced picolinic acid to tryptophan ratio as a urinary biomarker. iScience. 2021;24(11):103355.
   PubMed Web of Science ®Google Scholar
• Aggarwal A, Gupta R, Negi VS, et al. Urinary haptoglobin, alpha-1 anti-chymotrypsin and retinol binding protein identified by proteomics as potential biomarkers for lupus nephritis. Clin Exp Immunol. 2017;188(2):254–262.
   PubMed Web of Science ®Google Scholar
• Harden JL, Lewis SM, Lish SR, et al. The tryptophan metabolism enzyme L-kynureninase is a novel inflammatory factor in psoriasis and other inflammatory diseases. J Allergy Clin Immunol. 2016;137(6):1830–1840.
   PubMed Web of Science ®Google Scholar
• Kim YN, Kim DW, Jo HS, et al. Tat-CBR1 inhibits inflammatory responses through the suppressions of NF-kappaB and MAPK activation in macrophages and TPA-induced ear edema in mice. Toxicol Appl Pharmacol. 2015;286(2):124–134.
   PubMed Web of Science ®Google Scholar
• Ye Z, Liu Z, Henderson A, et al. Increased CYP4B1 mRNA is associated with the inhibition of dextran sulfate sodium-induced colitis by caffeic acid in mice. Exp Biol Med. 2009;234(6):605–616.
   Web of Science ®Google Scholar
• Kurashige M, Imamura M, Araki S, et al. The influence of a single nucleotide polymorphism within CNDP1 on susceptibility to diabetic nephropathy in Japanese women with type 2 diabetes. PLoS One. 2013;8(1):e54064.
   PubMed Web of Science ®Google Scholar
• Zhao YN, Xu GJ, Yang P. GBP1 exerts inhibitory effects on acute viral myocarditis by inhibiting the inflammatory response of macrophages in mice. Biochem Cell Biol. 2019; 97(4):454–462.
   PubMedGoogle Scholar
• Lundberg M, Krogvold L, Kuric E, et al. Expression of Interferon-Stimulated genes in insulitic pancreatic islets of patients recently diagnosed with type 1 diabetes. Diabetes. 2016;65(10):3104–3110.
   PubMed Web of Science ®Google Scholar
• Haque M, Singh AK, Ouseph MM, et al. Regulation of synovial inflammation and tissue destruction by guanylate binding protein 5 in synovial fibroblasts from patients with rheumatoid arthritis and rats with adjuvant-induced arthritis. Arthritis Rheumatol. 2021;73(6):943–954.
   PubMed Web of Science ®Google Scholar
• Feng S, Enosi Tuipulotu D, Pandey A, et al. Pathogen-selective killing by guanylate-binding proteins as a molecular mechanism leading to inflammasome signaling. Nat Commun. 2022;13(1):4395.
   PubMed Web of Science ®Google Scholar
• Fu R, Guo C, Wang S, et al. Podocyte activation of NLRP3 inflammasomes contributes to the development of proteinuria in lupus nephritis. Arthritis Rheumatol. 2017;69(8):1636–1646.
   PubMed Web of Science ®Google Scholar
• Peng X, Yang T, Liu G, et al. Piperine ameliorated lupus nephritis by targeting AMPK-mediated activation of NLRP3 inflammasome. Int Immunopharmacol. 2018;65:448–457.
   PubMed Web of Science ®Google Scholar
• Wandel MP, Kim BH, Park ES, et al. Guanylate-binding proteins convert cytosolic bacteria into caspase-4 signaling platforms. Nat Immunol. 2020;21(8):880–891.
   PubMed Web of Science ®Google Scholar